Abaloparatide - Latest Advances

Metabolic bone diseases : what's new in 2025

Journal: Revue medicale suisse

Published: January 22, 2026

Rapid fracture healing of the greater tuberosity fragment after shoulder hemiarthroplasty in a patient with daily abaloparatide injection: A case report.

Journal: Bone reports

Published: December 16, 2025

Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in Osteoporosis.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: December 09, 2025

Clarifying clinically treatment-naive status for osteoporosis patients.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: December 08, 2025

Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment.

Journal: International journal of molecular sciences

Published: November 24, 2025

Timeliness of Antiresorptive Consolidation After Anabolic Therapy for Primary Fracture Prevention: A U.S. Cohort Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 19, 2025

Recent Advances in Osteoporosis Therapeutics.

Journal: Annual review of medicine

Published: November 18, 2025

PTH Analog Therapy in CKD G4-G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease.

Journal: Journal of clinical medicine

Published: November 15, 2025

Bone Optimization for Perioperative Spine Patients: A Multidisciplinary Approach at a Single Academic Center.

Journal: Journal of clinical medicine

Published: October 30, 2025

Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1-34) analogs in women.

Journal: Biology of sex differences

Published: October 29, 2025

The Efficacy and Safety of Abaloparatide in Osteoporosis: A Systematic Review and Meta-Analysis.

Journal: Journal of clinical medicine

Published: October 11, 2025

A dual-active biological scaffold with in situ loaded Abaloparatide and bone marrow-derived mesenchymal stem cells synergistically regulatory T cell to promote bone regeneration.

Journal: Biomaterials advances

Published: October 05, 2025